STC2 and acute myeloid leukemia: The STC2 is positively correlated with TMB including CESC, acute myeloid leukemia (LAML), LUAD, prostate adenocarcinoma (PRAD), READ, THYM and negatively correlated with BRCA, and THCA (Figure 2B).